References
- Jadhav K, Gambhire M, Shaikh I, et al. Nasal drug delivery system-factors affecting and applications. Curr Drug Ther. 2007;2:27–38.
- Anaísa P, Ana F, Gilberto A, et al. Intranasal drug delivery: how, why and what for? J Pharm Sci. 2009;12:288–311.
- Hinchcliffe M, Illum L. Intranasal insulin delivery and therapy. Adv Drug Deliv Rev. 1999;35:199–234.
- Henry RC, Illum L, Gordon B, et al. Intranasal delivery: Physicochemical and therapeutic aspects. Int J Pharm. 2007;337:1–24.
- Illum L. Transport of drug from the nasal cavity to central nervous system. Eur J Pharm Sci. 2000;11:1–18.
- Illum L. Nasal drug delivery-possibilities, problems and solutions. J Control Release. 2003;87:187–198.
- Chien YW, Su KSE, Chang SF. Anatomy and physiology of the nose. In: Swarbrick, J, editor. Nasal systemic drug delivery; Drugs and pharmaceutical science. Marcel Dekker, New York 1989;39:1–19.
- Corbo DC, Liu JC, Chien YW. Characterization of the barrier properties of mucosal membranes. J Pharm Sci. 1990;79:202–206.
- Cevc G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit Rev Ther Drug Carrier Syst. 1996;13:257–388.
- Sahil MG, Sharad SP, Kisan RJ, et al. Clinical transfersome: a new technique for transdermal drug delivery. Int J Res Pharm Chem. 2011;1:735–740.
- Vineet B, Vikesh S, Anju S, et al. Transfersomes ultra flexible vesicles for transdermal delivery. Int J Pharma Sci Res. 2010;1:12–20.
- Banker GS, Rhodes CT. Modern Pharmaceutics. 3rd Ed, New York: Marcel Dekker Inc.; 1996; 728–734.
- Joseph BS. Optimization techniques in product formulation. J Soc Cosmet Chem. 1981;32:287–301.
- Bhupinder S, Manju D, Vandana S, et al. Optimizing drug delivery systems using systematic “design of experiments.” part ii: retrospect and prospects. Cri Rev Ther Drug Carr Sys. 2005;22:215–293.
- Kalanuria AA, Peterlin BL. A review of the pharmacokinetics, pharmacodynamics and efficacy of zolmitriptan in the acute abortive treatment of migraine. Clin Med Ther. 2009;1:397–413.
- Vyas TK, Babbar AK, Sharma RK, et al. Intranasal mucoadhesive microemulsions of zolmitriptan: preliminary studies on brain targeting. J Drug Target. 2005;13:317–324.
- Abd-Elal RM, Shamma RN, Rashed HM, et al. Transnasal zolmitriptan novasomes: in vitro preparation, optimization and in vivo evaluation of brain targeting efficiency. Drug Deliv. 2016;23:3374–3386.
- Santosh S, Sadhana S, Sunil J, et al. Poloxamer 407-based intranasal thermoreversible gel of zolmitriptan-loaded nanoethosomes: formulation, optimization, evaluation and permeation studies. J Lipo Res. 2016;26:313–323.
- Pitta SK. Preparation characterization and evaluation of zolmitriptan loaded transfersomes for nasal delivery using Box-Behnken design. Master Thesis, Kakatiya University; 2014.
- Malakar J, Sen OS, Nayak AK, et al. Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. Saudi Pharm J. 2012;20:355–363.
- Aslan N, Cebeci Y. Application of Box–Behnken design and response surface methodology for modeling of some Turkish coals. Fuel. 2007;86:90–97.
- Narendar D, Kishan V. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation. Drug Deliv. 2016;23:395–404.
- Sankar DG, Babu AN, Rajeswari A, et al. Spectrophotometric determination of zolmitriptan in pharmaceutical dosage forms. Asian J Chem. 2008;20:4960–4962.
- Ahmed TA. Preparation of transfersomes encapsulating sildenafil aimed for transdermal drug delivery: Plackett–Burman design and characterization. J Lipo Res. 2015;25:1–10.
- Hao J, Wang F, Wang X, et al. Development and optimization of baicalin-loaded solid lipid nanoparticles prepared by coacervation method using central composite design. Eur J Phar Sci. 2012;47:497–505.
- Dalpiaz A, Marchetti N, Cavazzini A, et al. Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC–ESI-MS/MS analysis: application to in vivo preclinical pharmacokinetic study. J Chromato B. 2012;901:72–78.
- Koteswari P, Sravanthi GP, Mounika M, et al. Formulation development and evaluation of zolmitriptan oral soluble films using 22 factorial designs. Int J Pharm Investig. 2016;6:201–206.
- Ahad A, Aqil M, Kohli K, et al. Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan. Nanomed. 2012;8:237–249.
- Liang H, Yang Q, Deng L, et al. Phospholipid-Tween 80 mixed micelles as an intravenous delivery carrier for paclitaxel. Drug Dev Ind Pharm. 2011;37:597–605.
- Sudhir V, Yan L, Rajeev G, et al. Quality by design approach to understand the process of nanosuspension preparation. Int J Pharm. 2011;377:185–198.
- Torrades F, Saiz Z, García-Hortal JA. Using central composite experimental design to optimize the degradation of black liquor by Fenton reagent. Desalination. 2011;268:97–102.
- Narendar D, Kishan V. Pharmacokinetic and pharmacodynamic studies of nisoldipine loaded solid lipid nanoparticles by central composite design. Drug Dev Ind Pharm. 2015;41:1968–1977.
- Suvarna G, Narendar D, Kishan V. Preparation, characterization and in vivo evaluation of rosuvastatin calcium loaded solid lipid nanoparticles. Int J Pharm Sci Nanotech. 2015;9:2779–2785.